RAPSN and congenital myasthenic syndrome: A majority of CMS cases, ~75%, involve mutations of genes encoding proteins for postsynaptic development or function; and among them, mutations in AChR subunits and Rapsn are prevalent (Engel et al., 2003; Engel et al., 2015; Engel and Sine, 2005).